30-Second Takeaway
- Favor protein plus vitamin D or multinutrient regimens over drugs when treating sarcopenia.
- Treat osteoporosis and fractures as markers of elevated short-term dementia risk in older adults.
- Support sustained antihypertensive adherence from midlife as a practical dementia-prevention strategy.
Week ending December 27, 2025
Targeting Sarcopenia, Frailty, Dementia Risk, and Treatment Burden in Older Adults
Protein plus vitamin D and multinutrient regimens improve sarcopenia outcomes
This network meta-analysis synthesized 59 RCTs including 5543 older adults with sarcopenia receiving nutritional or pharmacologic therapies. Multinutrition, protein alone, and protein plus vitamin D probably improve quality of life versus usual care with moderate-certainty evidence. Protein plus vitamin D probably improves handgrip strength by about 2 kg, and multinutrition may also increase strength, though with lower-certainty evidence. Drug interventions did not significantly improve handgrip or knee extension strength, or timed up and go, despite possible muscle mass gains.
Osteoporosis and fractures associated with higher dementia risk
This cohort of 176,150 Chinese adults ≥65 years without baseline cognitive impairment was followed for a median 2.2 years. Physician-diagnosed osteoporosis was associated with an 80% higher risk of all-cause dementia (HR 1.80, 95% CI 1.53-2.12). Dementia risk was higher in those with osteoporotic fractures (HR 2.43, 95% CI 1.83-3.23) than in osteoporotic patients without fractures (HR 1.63). Associations were similar for Alzheimer’s disease and vascular dementia, suggesting osteoporosis broadly signals increased dementia risk.
Sustained antihypertensive adherence lowers subsequent dementia risk
This longitudinal US cohort included 11,835 community-dwelling adults ≥50 years from the Health and Retirement Study. Hypertensive participants with persistent antihypertensive adherence over four years had a 27% lower dementia risk than low-adherence peers (HR 0.73, 95% CI 0.61-0.87). Dementia risk in the high-adherence group was similar to normotensive participants (HR 1.03, 95% CI 0.88-1.21). Results were consistent in APOE ε4 carriers and noncarriers, with no evidence of interaction.
High post-ED mortality in dementia; admin-only models predict poorly
This retrospective cohort studied 250,343 Traditional Medicare beneficiaries ≥66 years with dementia and an index ED visit in 2018. Most lived in the community pre-ED (83.9%), and 34.4% were hospitalized after the encounter. One-year mortality ranged from 18.4% in community dwellers not hospitalized to 47% in nursing home residents admitted and returned to nursing homes. Recent hospitalization predicted higher mortality, reaching 40.3% when hospitalized within the prior month. Administrative-data models had at best moderate discrimination for mortality and high costs, with most C-statistics ≤0.72.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.